Skip to main content
. 2020 Oct 1;20(6):129. doi: 10.3892/etm.2020.9258

Figure 2.

Figure 2

Comparison of other related indexes before and after treatment and correlation analysis with serum MALAT1 of patients from the RG. (A) Comparison of other related indexes of patients before and after treatment in the RG. (B) Correlation analysis of serum MALAT1 and NT-proBNP in patients with coronary heart disease. (C) Correlation analysis of serum MALAT1 and hs-CRP in patients with coronary heart disease. (D) Correlation analysis of serum MALAT1 and LDH in patients with coronary heart disease. (E) Correlation analysis of serum MALAT1 and CK-MB in patients with coronary heart disease. *P<0.05. MALAT1, metastasis associated lung adenocarcinoma transcript 1; RG, research group; hs-CRP, high sensitivity C-reactive protein; LDH, lactate dehydrogenase; CK-MB, creatine kinase-MB.